63U-28215-80993
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 229 / VA
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-17
Registered in v-safe
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
-
2021-05-09
Survey response — day 21, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Common coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-16
- 2022-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech |
Free text
Release 8 — day 21, dose 2
Symptoms: Common cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release